EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study

Roberto Montalti, Francesco Pepe, Gianluca Cassese, Gianluca Russo, Umberto Malapelle, Chiara Carlomagno, Mariano Cesare Giglio, Giacinto Falco, Mariantonietta Alagia, Giuseppe De Simone, Karen Geboes, Giancarlo Troncone und 2 weitere

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.109706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Roberto Montalti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, Division of HBP, Minimally Invasive and Robotic Surgery, Transplantation Service, Federico II University…. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Circulating Tumor DNA, Hepatectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Liver resection represents the cornerstone treatment for Colo-Rectal Liver Metastases (CRLM), but it is still followed by a high recurrence rate. The identification of a valid and reproducible predictor of recurrence can play a key role in correct and timely management of the disease. In this scenario, liquid biopsy may represent an integrative, less invasive, and easily manageable tool to clinically stratify colorectal cancer patients.We aimed to investigate the prognostic role of persistent circulating tumor DNA (ctDNA) signature on CRLM recurrence after liver resection. METHODS: A series of 51 consecutive patients undergoing liver resection for CRLM were prospectively enrolled between January 2020 and March 2023. Patients underwent liquid biopsy from peripheral blood samples before and after surgery. Other risk factors for disease recurrence were also investigated. RESULTS: Twenty-nine patients were found to be positive for one of the clinically relevant molecular alterations detected by NGS, at preoperative (T0) ctDNA analysis. At univariate analysis, total tumor size bigger than 60 mm (p = 0.046, HR 2.486) and postoperative persistence of ctDNA molecular signature (p = 0.024, HR 2.831) were significantly associated with recurrence. Multivariable Cox Regression analysis showed that only postoperative persistence of ctDNA molecular signature was associated with recurrence (p = 0.027, HR 2.766). Similarly, 1-3 yr DFS was significantly lower in the subgroup with persistence of molecular signature at liquid biopsy (100-49.5 % vs 57.1-21.4 %, p = 0.018). CONCLUSION: Postoperative persistence of ctDNA molecular signature could represent a useful tool to predict recurrence after liver resection for CRLM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsColorectal NeoplasmsCirculating Tumor DNAHepatectomyNeoplasm Recurrence, LocalHumansMaleFemaleProspective StudiesMiddle AgedAgedPrognosisLiquid BiopsyBiomarkers, TumorAdult

Stichwörter der Autor:innen

Circulating tumor DNAColorectal liver metastasesColorectal liver metastases recurrenceLiquid biopsy

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Medicine and Surgery, Division of HBP, Minimally Invasive and Robotic Surgery, Transplantation Service, Federico II University Hospital, 80131, Naples, Italy; Department of Public Health, Federico…
  • Department of Public Health, Federico II University, 80131, Naples, Italy.
  • Department of Clinical Medicine and Surgery, Division of HBP, Minimally Invasive and Robotic Surgery, Transplantation Service, Federico II University Hospital, 80131, Naples, Italy.
  • Department of Clinical Medicine and Surgery, Division of Oncology, University Federico II, Naples, Italy.
  • Department of Anesthesiology, Federico II University Hospital, Naples, Italy.
  • Oncology Centrum, Ghent University Hospital, Belgium.

Zitieren

APA

Montalti, R., Pepe, F., Cassese, G., Russo, G., Malapelle, U., Carlomagno, C., Giglio, M. C., Falco, G., Alagia, M., De Simone, G., Geboes, K., Troncone, G., Troisi, R. I., & Rompianesi, G. (2025). Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.109706

Vancouver

Montalti R, Pepe F, Cassese G, Russo G, Malapelle U, Carlomagno C, et al. Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.109706

BibTeX
@article{Montalti2025,
  author = {Montalti, Roberto and Pepe, Francesco and Cassese, Gianluca and Russo, Gianluca and Malapelle, Umberto and Carlomagno, Chiara and Giglio, Mariano Cesare and Falco, Giacinto and Alagia, Mariantonietta and De Simone, Giuseppe and Geboes, Karen and Troncone, Giancarlo and Troisi, Roberto Ivan and Rompianesi, Gianluca},
  title = {Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.109706}
}
Kostenlos starten →